191 related articles for article (PubMed ID: 35211625)
1. Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.
Shi S; Ma HY; Han XY; Sang YZ; Yang MY; Zhang ZG
Biomed Res Int; 2022; 2022():8600419. PubMed ID: 35211625
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
Ma GY; Shi S; Zhang YR; Guo ZB; Bai WW; Zhang ZG
Oncol Lett; 2022 Nov; 24(5):412. PubMed ID: 36245823
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta‑analysis and bioinformatics analysis.
Sun J; Bai YK; Fan ZG
Oncol Lett; 2023 Jun; 25(6):240. PubMed ID: 37181948
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
Guo W; Zhang M; Chen Y; Guo S
J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
[TBL] [Abstract][Full Text] [Related]
6. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract][Full Text] [Related]
8. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
[No Abstract] [Full Text] [Related]
9. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
10. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
12. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
[TBL] [Abstract][Full Text] [Related]
13. Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.
Liang JF; Wang HK; Xiao H; Li N; Cheng CX; Zhao YZ; Ma YB; Gao JZ; Bai RB; Zheng HX
J Exp Clin Cancer Res; 2010 Jun; 29(1):71. PubMed ID: 20565704
[TBL] [Abstract][Full Text] [Related]
14. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
[TBL] [Abstract][Full Text] [Related]
15. Expressions of the γ2 chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis.
Xue LY; Zou SM; Zheng S; Liu XY; Wen P; Yuan YL; Lin DM; Lu N
Chin J Cancer; 2011 Jan; 30(1):69-78. PubMed ID: 21192846
[TBL] [Abstract][Full Text] [Related]
16. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
[TBL] [Abstract][Full Text] [Related]
17. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
Wu J; Zhang JR; Jiang XQ; Cao XG
Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
[TBL] [Abstract][Full Text] [Related]
18. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
Yu XZ; Guo ZY; Di Y; Yang F; Ouyang Q; Fu DL; Jin C
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):104-109. PubMed ID: 28119265
[TBL] [Abstract][Full Text] [Related]
19. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
20. Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC.
Güttlein LN; Benedetti LG; Fresno C; Spallanzani RG; Mansilla SF; Rotondaro C; Raffo Iraolagoitia XL; Salvatierra E; Bravo AI; Fernández EA; Gottifredi V; Zwirner NW; Llera AS; Podhajcer OL
Mol Cancer Res; 2017 Mar; 15(3):304-316. PubMed ID: 28031408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]